Connect Biopharma Holdings Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Connect Biopharma Holdings Limited generated cash of -$47,930,000, which is more than the previous year. Cash used in financing activities reached the amount of -$246,000 last year. Net change in cash is therefore $26,997,000.
Cash Flow
| 2019 | -13.09M | -484.70K | -57.45K |
|---|---|---|---|
| 2020 | -167.16M | 2.93M | 918.76M |
| 2021 | -544.92M | -34.02M | 1.31B |
| 2022 | -99.26M | -83.44M | -91.28K |
| 2023 | -47.93M | 75.15M | -246K |
CNTB Cash Flow Statement (2019 โ 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 79.01M | 249.30M | 1.01B | 308.97M | 58.26M |
Operating activities | |||||
Net income | -59.38M | -116.11M | -1.30B | -779.22M | -24.46M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 988K | 1.01M | 4.08M | 1.44M | 114.61K |
Stock-based compensation expense | 3.25M | 1.00M | 8.98M | 3.85M | 562.17K |
| Deferred income tax benefit | 3.25M | 1.00M | 8.98M | 3.85M | 562.17K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 1.04M | 3.37K | -16.11K | -9.35K | -439 |
Inventories | 0 | -3.37K | 16.11K | 9.35K | 439 |
Accounts payable | -4.27M | 375.65K | 56.60M | 1.85M | 2.80M |
Cash generated by operating activities | -47.93M | -99.26M | -544.92M | -167.16M | -13.09M |
Investing activities | |||||
Purchases Of Investments | -32.60M | -113.70M | -114.5M | -106.6M | -23.64M |
Investments In Property Plant And Equipment | -294K | -4.28M | -47.52M | -15.30M | -155.52K |
Acquisitions Net | 2.94M | 79.16K | 304K | 349K | 329 |
Cash generated by investing activities | 75.15M | -83.44M | -34.02M | 2.93M | -484.70K |
Financing activities | |||||
Common Stock Issued | 44K | 18K | 1.43B | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -3.67M | 0 | 0 |
Repayments of term debt | -290K | -222K | -805K | -538K | -63.6K |
Cash used in financing activities | -246K | -91.28K | 1.31B | 918.76M | -57.45K |
Net Change In Cash | 26.99M | -168.93M | 696.80M | 701.10M | -13.43M |
Cash at end of period | 106.00M | 80.37M | 1.70B | 1.01B | 44.82M |
| Data source | Data source | Data source |